source
- Stipple Bio wins Endpoints 2026 award for precision pancreatic cancer therapyStipple Bio was announced as the winner of the Endpoints 2026 competition, recognized for its work in precision medicine. The company’s approach focuses on developing targeted treatments for pancr…
- Medra, 2026 Endpoints 11 winner, aims to build self-driving labsMedra, the recent winner of the Endpoints 11 2026 competition, announced plans to develop autonomous laboratory systems. The company's founder, who just completed a PhD in robotics, said the goal…